Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
245.24B
Market cap245.24B
Price-Earnings ratio
12.82
Price-Earnings ratio12.82
Dividend yield
3.34%
Dividend yield3.34%
Average volume
13.38M
Average volume13.38M
High today
$99.04
High today$99.04
Low today
$97.58
Low today$97.58
Open price
$98.44
Open price$98.44
Volume
5.88M
Volume5.88M
52 Week high
$105.84
52 Week high$105.84
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

The current Merck(MRK) stock price is $98.80, with a market capitalization of 245.24B. The stock trades at a price-to-earnings (P/E) ratio of 12.82 and offers a dividend yield of 3.3%.

During the trading session on 2025-12-11, Merck(MRK) shares reached a daily high of $99.04 and a low of $97.58. At a current price of $98.80, the stock is +1.3% higher than the low and still -0.2% under the high.

Trading volume for Merck(MRK) stock has reached 5.88M, versus its average volume of 13.38M.

Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.

Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.

MRK News

Nasdaq 42m
Ex-Dividend Reminder: Gilead Sciences, Merck and Horace Mann Educators

Looking at the universe of stocks we cover at Dividend Channel, on 12/15/25, Gilead Sciences Inc (Symbol: GILD), Merck & Co Inc (Symbol: MRK), and Horace Mann E...

Ex-Dividend Reminder: Gilead Sciences, Merck and Horace Mann Educators
Simply Wall St 6h
Is It Smart To Buy Merck & Co., Inc. Before It Goes Ex-Dividend?

It looks like Merck & Co., Inc. ( ) is about to go ex-dividend in the next three days. The ex-dividend date occurs one day before the record date, which is the...

Is It Smart To Buy Merck & Co., Inc. Before It Goes Ex-Dividend?
The Motley Fool 2d
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump

The company is finding ways to overcome the headwinds it will encounter in the medium term. After lagging the market over the past couple of years, Merck (MRK...

Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump

Analyst ratings

52%

of 27 ratings
Buy
51.9%
Hold
48.1%
Sell
0%

More MRK News

Barchart 3d
These 2 High-Yield Dividend Stocks Are Some of the Safest Buys Right Now

The Fed just reminded everyone that the path to lower rates won't be a straight line. In late October, policymakers delivered a second cut this year. The benchm...

Nasdaq 3d
Merck's CAPVAXIVE Added To Publicly Funded Adult Immunization Program In Saskatchewan

(RTTNews) - Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, announced Monday that the province of Saskatchewan has added CAPVAXIVE, a 21-vale...

Merck's CAPVAXIVE Added To Publicly Funded Adult Immunization Program In Saskatchewan
Simply Wall St 4d
Merck: Evaluating Valuation After Dividend Hike, New Drug Approvals and Upbeat Analyst Upgrades

Merck (MRK) has been in the spotlight after a cluster of investor friendly moves, from a higher dividend and fresh drug approvals to upbeat Wall Street commenta...

Merck: Evaluating Valuation After Dividend Hike, New Drug Approvals and Upbeat Analyst Upgrades
The Motley Fool 4d
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them. Just because a stock offers a high y...

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Simply Wall St 6d
Is It Too Late To Consider Merck After Its Recent 20.3% Share Price Jump?

Wondering if Merck at around $100 a share still looks attractive or if the easy gains are behind it? This breakdown outlines key considerations to help you asse...

Is It Too Late To Consider Merck After Its Recent 20.3% Share Price Jump?
Nasdaq 6d
Do These 3 Healthcare Stocks Need a Checkup?

Key Points Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb has a 5% yield and is off its 2023 highs by nearly...

Do These 3 Healthcare Stocks Need a Checkup?
Nasdaq 6d
Is This Pharmaceutical Giant a Buy After a Major Acquisition?

Key Points Merck's newest acquisition could help it launch a promising flu candidate. Several other ongoing developments are helping paint a bright post-Keytr...

Is This Pharmaceutical Giant a Buy After a Major Acquisition?

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.